Which benign tumour most commonly causes nipple discharge?
A. Phyllodes
B. Papilloma
C. Lipoma
D. Fibroadenoma
E. Hamartoma
Correct answer: B
Age 30 with sclerosing adenosis
Likely symptom?
A. Fever
B. Burning unilateral pain
C. Mass or focal pain
D. Nipple retraction
E. Peau d’orange
Correct answer: C
Painful nodularity improves post‑menopause
A 52‑year‑old experiences relief from breast nodularity after menopause.
Most likely diagnosis?
A. Fibrocystic changes
B. Lipoma
C. Fibroadenoma
D. Radial scar
E. Phyllodes tumour
Correct answer: A
Triple assessment components
Which combination is correct?
A. Clinical exam + ultrasound only
B. Ultrasound + mammogram
C. Clinical exam + imaging + histology
D. FNA + MRI + biopsy
E. Physical exam + blood tests
Correct answer: C
Blue‑domed cyst histology
Which is true?
A. Thick‑walled apocrine cyst
B. Thin‑walled apocrine‑lined cyst
C. Fibrofatty tumour
D. Contains stromal overgrowth
E. Ductal epithelial papillary fronds
Correct answer: B
Which benign tumour resembles fibroadenoma but grows faster?
A. Hamartoma
B. Lipoma
C. Phyllodes tumour
D. Radial scar
E. Intraduct papilloma
Correct answer: C
A stable fibroadenoma confirmed via triple assessment.
Management?
A. Surgical excision
B. Reassurance only
C. Radiofrequency ablation
D. MRI surveillance
E. Chemotherapy
Correct answer: B
38‑year‑old with well‑circumscribed fatty breast lump which is soft, mobile, painless.
Diagnosis?
A. Hamartoma
B. Lipoma
C. Fibroadenoma
D. Sclerosing adenosis
E. Abscess
Correct answer: B – Lipoma
In which scenario is imaging not needed?
A. Classic cyclical mastalgia in a 25‑year‑old
B. Bloody nipple discharge
C. Growing breast lump
D. Unilateral hard mass
E. Palpable thickening in woman >50
Correct answer: A
23‑year‑old with tender, cyclical breast lump.
A lump enlarges pre‑menses and becomes less obvious afterward.
Most likely diagnosis?
A. Fibroadenoma
B. Fibrocystic changes
C. Lipoma
D. DCIS
E. Phyllodes tumour
Correct answer: B – Fibrocystic changes
A lesion appears papillary on ultrasound.
Investigation of choice?
A. FNA
B. Core needle biopsy
C. PET scan
D. MRI
E. Blood tests
Correct answer: B – Core needle biopsy
Rule‑in: Needed to differentiate papilloma from carcinoma.
Rule‑out:
FNA insufficient to assess atypia.
A 45‑year‑old has an enlarging breast mass suspected to be a borderline Phyllodes.
Management?
A. Observe
B. Wide local excision
C. Lumpectomy without margins
D. Radiation alone
E. Needle aspiration
Correct answer: B – Wide local excision
Rule‑in: Required to prevent recurrence.
Rule‑out:
Others inadequate or inappropriate.
55‑year‑old with firm, rapidly enlarging breast mass. A firm, rapidly enlarging breast lump is noted. Core biopsy shows stromal overgrowth.
Diagnosis?
A. Fibroadenoma
B. Phyllodes tumour
C. Lipoma
D. Abscess
E. Hamartoma
Correct answer: B – Phyllodes tumour
Rule‑in: Fast growth + stromal overgrowth.
Rule‑out:
A: Slow growth
C: Fatty
D: Painful, red, febrile
E: Contains mixed normal tissues
Stellate lesion on mammography
A star‑shaped lesion with translucent centre is seen incidentally.
Most likely diagnosis?
A. Radial scar
B. Phyllodes tumour
C. Lipoma
D. Fibroadenoma
E. Hamartoma
Correct answer: A – Radial scar
Rule‑in: Stellate/rosette mammographic pattern.
Rule‑out:
Others do not show this pattern.
A 40‑year‑old woman has unilateral bloody nipple discharge, but no mass.
Most likely diagnosis?
A. Intraduct papilloma
B. Fibrocystic disease
C. Mastitis
D. DCIS
E. Phyllodes tumour
Correct answer: A – Intraduct papilloma
Rule‑in: Classic: bloody discharge, no mass.
Rule‑out:
B: Usually pain + cysts
C: Signs of infection
D: Usually abnormal imaging + calcifications
E: Forms a mass
Clear cystic lesion with blue‑domed appearance is a breast lesion on imaging. It is thin‑walled, multiple, and contains pale fluid.
Most likely diagnosis?
A. Fibrocystic changes
B. Fibroadenoma
C. Lipoma
D. Phyllodes tumour
E. Intraduct papilloma
Correct answer: A – Fibrocystic changes
Rule‑in: Blue‑domed cysts, multiple, benign.
Rule‑out:
B: Solid tumour
C: Fat only
D: Fast‑growing stromal lesion
E: Nipple discharge typically
A 38‑year‑old has bilateral breast pain, normal exam and normal mammogram. She is very anxious.
Best management?
A. Tamoxifen
B. Reassurance
C. Excision biopsy
D. MRI
E. Antibiotics
Correct answer: B – Reassurance
Rule‑in: Mastalgia with normal exam + normal imaging.
Rule‑out:
A: Only for severe refractory pain
C: No mass
D: Unnecessary
E: No infection
A 24‑year‑old woman finds a smooth, rubbery, highly mobile breast lump <3 cm “breast mouse”.
Diagnosis?
A. Phyllodes tumour
B. Fibroadenoma
C. Hamartoma
D. Lipoma
E. Radial scar
Correct answer: B – Fibroadenoma
Rule‑in: Young woman, mobile, well‑defined, “breast mouse”.
Rule‑out:
A: Larger/faster growth
C: Contains fat + glandular tissue; “breast within breast” on imaging
D: Soft, fatty
E: Stellate mammogram finding
A 32‑year‑old woman reports bilateral breast pain that worsens 1–2 weeks before menstruation and improves afterwards. No lumps are felt.
Most likely diagnosis?
A. Fibroadenoma
B. Fibrocystic changes
C. Non‑cyclic mastalgia
D. Intraduct papilloma
E. Phyllodes tumour
Correct answer: B – Fibrocystic changes
Rule‑in: Cyclical, hormone‑related pain; common in 20–50 years.
Rule‑out:
A: Usually painless, mobile lump
C: Non‑cyclic is unilateral, sharp/stabbing
D: Gives nipple discharge
E: Fast‑growing mass, not cyclical
A 56‑year‑old woman presents for breast screening. She had menarche at 11, menopause at 57, first pregnancy at 34, and has been on HRT for 3 years. BMI 31. Which single factor below is NOT a recognised risk factor for breast carcinoma?
A. Early menarche
B. Late menopause
C. Obesity (postmenopausal)
D. First pregnancy before age 25
E. HRT use
Correct: D – First pregnancy before 25
Rule‑in: Early menarche, late menopause, post‑menopausal obesity, HRT, older age at first pregnancy (or nulliparity) all ↑ risk.
Rule‑out: First pregnancy before 25 lowers/doesn’t raise risk (older first pregnancy >30 is a risk).
A path report describes malignant epithelial cells arising in the terminal duct lobular unit (TDLU). What is the most accurate classification?
A. Sarcoma
B. Adenocarcinoma
C. Lymphoma
D. Melanoma
E. Phyllodes tumour
Correct: B – Adenocarcinoma
Rule‑in: Breast carcinoma is an adenocarcinoma from glandular epithelium of the TDLU.
Rule‑out: Others arise from stroma (sarcoma/phyllodes), lymphoid tissue, or melanocytes.
A 65‑year‑old has an invasive breast cancer. Which subtype is most common?
A. Invasive ductal carcinoma (IDC)
B. Invasive lobular carcinoma (ILC)
C. Medullary carcinoma
D. Mucinous (colloid) carcinoma
E. Papillary carcinoma
Correct: A – IDC
Rule‑in: IDC ≈ 75–85% of invasive cases.
Rule‑out: ILC ≈ ~10%; others are less frequent.
A tumour shows loss of E‑cadherin on immunohistochemistry and a diffuse stromal “single‑file” pattern. What is it?
A. Invasive ductal carcinoma
B. Invasive lobular carcinoma
C. DCIS
D. LCIS
E. Paget’s disease
Correct: B – ILC
Rule‑in: Loss of E‑cadherin is characteristic for lobular lesions (ILC/LCIS).
Rule‑out: Ductal lesions retain E‑cadherin; Paget’s is an epidermal manifestation of ductal disease.
A 48‑year‑old’s tumour is ER‑negative, PR‑negative, HER2‑negative. Which is true?
A. It is usually indolent
B. It lacks the three common receptors and is often aggressive
C. It is best treated with endocrine therapy alone
D. Trastuzumab is first‑line
E. It cannot receive chemotherapy
Correct: B
Rule‑in: Triple‑negative tumours lack ER/PR/HER2 and are typically aggressive; chemo is mainstay (often neoadjuvant).
Rule‑out: Endocrine and HER2‑targeted agents won’t work; not indolent.